Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have previously reported that
intercellular adhesion molecule-3
(
ICAM-3
) is associated with an increase of cellular radio-resistance and cancer cell proliferation. In this study, we hypothesized that
ICAM-3
has an additional effect on cancer cell migration and invasion because molecules induced by
ICAM-3
are known as regulators of cell migration and invasion. To examine this hypothesis, we used NCI-H1299 non-small cell lung cancer (NSCLC) cell line (p53 and PTEN null cell) and constructed an
ICAM-3
-over-expressing stable transfectant, which exhibited increased cell migration and invasion. The increased migration and invasion resulted from up-regulation of expression and activities of MMP-2 and MMP-9.
ICAM-3
also increased Akt phosphorylation, which caused an increase in cellular migration/invasion and
MMP
activities. Activity of several transcriptional factors located downstream in the Akt pathway was also tested, and constitutive activation of adenosine 3', 5'-monophosphate response element-binding protein (CREB) by
ICAM-3
was detected. Blockage of the Akt pathway attenuated CREB activation, and a decrease in CREB expression reduced cellular migration/invasion and activity of MMPs. This result indicates that CREB functions in the signaling pathway between Akt and
MMP
. We also showed
ICAM-3
-induced cell migration and invasion in NCI-H460 NSCLC cells (wild-type p53 and PTEN cell) through the same signaling pathway. Taken together, our findings suggest that
ICAM-3
stimulates cancer cell migration/invasion via
ICAM-3
/Akt/CREB/
MMP
pathway regardless of p53 and PTEN status, and this reflects the possibility that
ICAM-3
could be considered as a candidate for anti-cancer drug development and as a cancer diagnostic marker.
...
PMID:ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. 1995 47